In Part 2 of this episode of Voices of Wisdom, Dr. Dana Hartl continues her conversation with Dr. David Pattison, diving deeper into radioactive iodine therapy for thyroid cancer. They discuss the biological mechanisms of I-131, key differences from external beam radiation, and evolving strategies for personalized treatment. Dr. Pattison also explores future advancements, including re-differentiation therapy and the role of nuclear medicine in optimizing patient care.
Feel free to send your questions or suggestions about future episodes to [email protected].
To subscribe to receive info about upcoming TIROxMDS webinars, click here: tiro.expert/subscribe

Ver todos los episodios